The Ethics of Switch/Simplify in Antiretroviral Trials: Non-Inferior or Just Inferior?

Open Access

Essays are opinion pieces on a topic of broad interest to a general medical audience.

Andrew Carr ,

* E-mail: acarr@stvincents.com.au

Affiliations Clinical Research Program, Centre for Applied Medical Research, St Vincent's Hospital, Sydney, Australia, HIV/Immunology/Infectious Diseases Unit, St Vincent's Hospital, Sydney, Australia
⨯
Jennifer Hoy,

Affiliations Infectious Diseases Unit, Alfred Hospital, Melbourne, Australia, Department of Infectious Diseases, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia
⨯
Anton Pozniak

Affiliation Chelsea and Westminster Hospital, London, United Kingdom
⨯

Reader Comments

The diminishing antiretroviral drug pipeline
http://plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001240#article1.body1.sec8.p1

The anti-retroviral pipeline has been strong for a decade and seems to still be strong, eg as reported in the Treatment Action Group/i-Base annual Pipeline Reports for 2011 and 2012

No competing interests declared.

Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Cardiovascular disease risk
Is the Subject Area "Cardiovascular disease risk" applicable to this article?

Thanks for your feedback.
Quality of life
Is the Subject Area "Quality of life" applicable to this article?

Thanks for your feedback.
HIV prevention pills
Is the Subject Area "HIV prevention pills" applicable to this article?

Thanks for your feedback.